| NCT ID | NCT02755974 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Imperial College London |
| Condition | Pulmonary Disease, Chronic Obstructive |
| Study Type | OBSERVATIONAL |
| Enrollment | 300 participants |
| Start Date | 2009-01 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 300 participants in total. It began in 2009-01 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The London COPD exacerbation (EXCEL) cohort builds on an established cohort started in 1995 and designed to study COPD exacerbations and their impact on health-status and disease progression.
Eligibility Criteria
Inclusion Criteria: * Forced Expiratory Volume in 1 sec (FEV1)/Forced Vital Capacity (FVC) ratio of \<0.70 * Able and willing to give informed and written consent Exclusion Criteria: * Patients with a history of asthma, bronchiectasis, carcinoma of the bronchus, or other significant respiratory disease were excluded. * Patients on Immunosuppressive medications or with active cancer * Long term steroid therapy * Age \<40 years at recruitment
Contact & Investigator
Jadwiga Wedzicha
PRINCIPAL INVESTIGATOR
Imperial College London
Frequently Asked Questions
Who can join the NCT02755974 clinical trial?
This trial is open to participants of all sexes, aged 40 Years or older, up to 100 Years, studying Pulmonary Disease, Chronic Obstructive. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT02755974 currently recruiting?
Yes, NCT02755974 is actively recruiting participants. Contact the research team at j.wedzicha@imperial.ac.uk for enrollment information.
Where is the NCT02755974 trial being conducted?
This trial is being conducted at London, United Kingdom.
Who is sponsoring the NCT02755974 clinical trial?
NCT02755974 is sponsored by Imperial College London. The principal investigator is Jadwiga Wedzicha at Imperial College London. The trial plans to enroll 300 participants.